ANSYS (NASDAQ:ANSS – Get Free Report) had its price objective boosted by analysts at Rosenblatt Securities from $335.00 to $340.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the software maker’s stock. Rosenblatt Securities’ target price would suggest a potential downside of 0.14% from the stock’s previous close.
Other equities research analysts have also issued reports about the stock. Robert W. Baird increased their target price on shares of ANSYS from $350.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. StockNews.com lowered shares of ANSYS from a “buy” rating to a “hold” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, ANSYS presently has an average rating of “Hold” and an average target price of $348.33.
View Our Latest Research Report on ANSS
ANSYS Trading Up 1.1 %
ANSYS (NASDAQ:ANSS – Get Free Report) last posted its earnings results on Wednesday, February 19th. The software maker reported $3.65 earnings per share for the quarter, missing the consensus estimate of $3.97 by ($0.32). The firm had revenue of $882.17 million during the quarter, compared to analyst estimates of $864.46 million. ANSYS had a return on equity of 12.96% and a net margin of 22.62%. On average, analysts predict that ANSYS will post 8.32 EPS for the current year.
Insider Buying and Selling
In related news, Director Glenda Dorchak sold 200 shares of the firm’s stock in a transaction on Monday, January 13th. The shares were sold at an average price of $336.62, for a total transaction of $67,324.00. Following the sale, the director now directly owns 3,430 shares in the company, valued at $1,154,606.60. This trade represents a 5.51 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.46% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in ANSS. Raymond James & Associates grew its position in ANSYS by 0.4% in the third quarter. Raymond James & Associates now owns 10,822 shares of the software maker’s stock valued at $3,448,000 after purchasing an additional 46 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in ANSYS by 6.5% in the third quarter. Sequoia Financial Advisors LLC now owns 1,504 shares of the software maker’s stock valued at $479,000 after purchasing an additional 92 shares in the last quarter. Signaturefd LLC grew its position in ANSYS by 7.0% in the third quarter. Signaturefd LLC now owns 1,334 shares of the software maker’s stock valued at $425,000 after purchasing an additional 87 shares in the last quarter. International Assets Investment Management LLC bought a new position in ANSYS in the third quarter valued at $54,820,000. Finally, IFM Investors Pty Ltd grew its position in ANSYS by 2.5% in the third quarter. IFM Investors Pty Ltd now owns 18,003 shares of the software maker’s stock valued at $5,736,000 after purchasing an additional 434 shares in the last quarter. Institutional investors own 92.39% of the company’s stock.
About ANSYS
ANSYS, Inc develops and markets engineering simulation software and services for engineers, designers, researchers, and students in the United States, Japan, Germany, China, Hong Kong, South Korea, rest of Europe, the Middle East, Africa, and internationally. It offers structural analysis product suite that provides simulation tools for product design and optimization; the Ansys Mechanical product, an element analysis software; LS-DYNA solver for multiphysics simulation; and power analysis and optimization software suite.
Further Reading
- Five stocks we like better than ANSYS
- What is Short Interest? How to Use It
- These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Palantir Stock Skids—How Much Further Can It Fall?
- With Risk Tolerance, One Size Does Not Fit All
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
Receive News & Ratings for ANSYS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANSYS and related companies with MarketBeat.com's FREE daily email newsletter.